Skip to main content
Clinical Trials/NCT04024670
NCT04024670CompletedNot Applicable

The Impact of Arts-Based Interventions on Patient Hospital Experience for Patients on a High-Risk Obstetrics and Bone Transplant Units

University of Alabama at Birmingham1 site in 1 country148 target enrollmentStarted: January 1, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
148
Locations
1
Primary Endpoint
Evaluate patient experience during the course of intervention using name of survey

Study Overview

Brief Summary

nuts and bolts

Detailed Description

interventions and timing of interventions

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Inpatient on either Bone Marrow Transplant ICU or High Risk Obstetrics Unit
  • •Estimated length of stay 2 or more weeks
  • •Patients who will potentially benefit from the AIM experience
  • •Additional Inclusion Criteria:
  • •For the High Risk Obstetrics Unit group (hand-sewing), patients should be physically able to participate in hand-sewing activity.
  • •For the Bone Marrow Transplant IUC group (story-telling/poetry), patients should be physically able to participate in story-telling/poetry activity.

Exclusion Criteria

  • •Patient too ill
  • •Complex medical condition that requires therapies which would not allow time for participation
  • •Declined to participate

Arms & Interventions

BMT Standard of Care

No Intervention

SOC

Patients on a high-risk obstetrics unit with an anticipated stay of two or more weeks

Active Comparator

patients in this group will receive twice weekly sewing and embroidery interactions with a professional artist in residence.

Intervention: Arts Intervention (Other)

Patients on a bone marrow transplant unit with an anticipated stay of two or more weeks

Active Comparator

patients in this group will receive twice weekly visits with a professional storyteller.

Intervention: Arts Intervention (Other)

HRO Standard of Care

No Intervention

SOC

Outcomes

Primary Outcomes

Evaluate patient experience during the course of intervention using name of survey

Time Frame: week 3 - weekly up to 10 weeks

define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best

Evaluate patient experience during the course of intervention using name of survey

Time Frame: Baseline at admissions

define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best

Evaluate patient experience during the course of intervention using name of survey

Time Frame: Baseline - end of week 1

define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best

Evaluate patient experience during the course of intervention using name of survey

Time Frame: week 1- week 2

define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best

Evaluate patient experience during the course of intervention using name of survey

Time Frame: week 2 - week 3

define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kimberly Kirklin

Principal Investigator

University of Alabama at Birmingham

Study Sites (1)

Loading locations...

Similar Trials